Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB
Alberto Piubello, Tom Decroo, Leen Rigouts, Adamou Mfopa et al.
Citations
2 citations
Journal
IJTLD OPEN
Topics
Antimicrobial Resistance in Staphylococcus
Field-Weighted Citation Impact (FWCI)
2.79
article
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB
Alberto Piubello, Tom Decroo, Leen Rigouts, Adamou Mfopa, Bouke C. de Jong, Eric Adéhossi, Saïdou Mamadou, Rawan Moussa, I. Hamidou, Assiatou Gagara-Issoufou, Mahamadou Bassirou Souleymane, A Soumana, Souleymane Halidou Moussa, Ibrahim Maman Lawan, A.-L.C. Aboubacar, A-A.A. Kabirou
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
IJTLD OPENVol. 2(8)
Institutions
Université Abdou Moumouni (NE), University of Antwerp (BE), Centre Hospitalier de Douai (FR), United Nations Children's Fund Niger (NE), Université André Salifou (NE), Damien Foundation (BD), Ministère de la Santé Publique (NE), Université de Maradi (NE), National Hospital Niamey (NE), Instituut voor Tropische Geneeskunde (BE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB — Alberto Piubello, Tom Decroo, et al. · IJTLD OPEN (2025) | TGRS Research Map | TGRS